277 related articles for article (PubMed ID: 24755857)
1. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
2. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
3. Viridans group streptococci in febrile neutropenic cancer patients: what should we fear?
Freifeld AG; Razonable RR
Clin Infect Dis; 2014 Jul; 59(2):231-3. PubMed ID: 24755859
[No Abstract] [Full Text] [Related]
4. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
5. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
[TBL] [Abstract][Full Text] [Related]
6. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.
Carratalá J; Alcaide F; Fernández-Sevilla A; Corbella X; Lińares J; Gudiol F
Clin Infect Dis; 1995 May; 20(5):1169-73. PubMed ID: 7619995
[TBL] [Abstract][Full Text] [Related]
9. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
Bruckner L; Gigliotti F
Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
[TBL] [Abstract][Full Text] [Related]
10. Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients.
Sahasrabhojane P; Galloway-Peña J; Velazquez L; Saldaña M; Horstmann N; Tarrand J; Shelburne SA
Int J Antimicrob Agents; 2014 Jun; 43(6):558-62. PubMed ID: 24721231
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility.
Shargian L; Paul M; Nachshon T; Ayada G; Nesher L; Raanani P; Ben-Zvi H; Henig O; Yahav D
Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):177-182. PubMed ID: 36502498
[TBL] [Abstract][Full Text] [Related]
13. Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease.
Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
Clin Microbiol Infect; 2004 Oct; 10(10):899-903. PubMed ID: 15373884
[TBL] [Abstract][Full Text] [Related]
14. Species-specific difference in antimicrobial susceptibility among viridans group streptococci.
Chun S; Huh HJ; Lee NY
Ann Lab Med; 2015 Mar; 35(2):205-11. PubMed ID: 25729722
[TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
16. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases.
Ergin A; Eser ÖK; Hasçelik G
New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer.
Shelburne SA; Chaftari AM; Jamal M; Al Wohoush I; Jiang Y; Abughazaleh S; Cairo J; Raad S; Debiane L; Raad I
Am J Infect Control; 2014 Oct; 42(10):1127-9. PubMed ID: 25278410
[TBL] [Abstract][Full Text] [Related]
19. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
[TBL] [Abstract][Full Text] [Related]
20. Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.
Prabhu RM; Piper KE; Litzow MR; Steckelberg JM; Patel R
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):832-8. PubMed ID: 16331335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]